Price T Rowe Associates Inc Athersys, Inc Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.18 - $0.86 $3,241 - $15,489	-18,011 Reduced 15.67%	96,900 $25,000
Q1 2022 May 16, 2022	BUY	$0.6 - $1.06 $27,600 - $48,760	46,000 Added 66.75%	114,911 $70,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $70,210 - $115,639	-82,600 Reduced 54.52%	68,911 $62,000
Q2 2021 Aug 16, 2021	BUY	$1.41 - $1.94 $6,875 - $9,459	4,876 Added 3.33%	151,511 $218,000
Q1 2021 May 17, 2021	SELL	$1.61 - $2.77 $23,597 - $40,599	-14,657 Reduced 9.09%	146,635 $264,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.24 $250,002 - $361,294	161,292 New	161,292 $282,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.